CARsgen Therapeutics Announces HK$470 Million Top-Up Placing and Subscription to Fund Global CAR T-Cell R&D and Expansion
CARsgen Therapeutics Announces HK\$470 Million Share Placing...
Sign in to continue:
CARsgen Therapeutics Announces HK\$470 Million Share Placing...
Details for Shareholders and Investors Price-Sensitive In...
China Gold International Resources Reports Record Q1 2026 Re...
RemeGen Co., Ltd. Announces Discloseable RMB 453 Million Inv...
China Frontier Technology Group: Supplemental Announcement o...
Ausnutria Dairy Corporation Ltd Clarifies Final Dividend Det...
IDT International Limited Announces Major AI Server Purchase...
Key Points of the Announcement Listing Approval: The Ho...
Scholar Education Group: Voluntary Share Purchase Update ...
Jiu Rong Holdings Limited: Update on Overdue Borrowing and L...